HTLZF Stock - Hamilton Thorne Ltd.
Unlock GoAI Insights for HTLZF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $67.23M | $55.87M | $52.35M | $39.78M | $35.36M |
| Gross Profit | $33.85M | $25.72M | $26.21M | $20.39M | $19.03M |
| Gross Margin | 50.4% | 46.0% | 50.1% | 51.3% | 53.8% |
| Operating Income | $277,997 | $12.59M | $3.82M | $2.85M | $3.22M |
| Net Income | $-607,022 | $1.91M | $2.43M | $971,235 | $793,275 |
| Net Margin | -0.9% | 3.4% | 4.6% | 2.4% | 2.2% |
| EPS | $-0.00 | $0.01 | $0.02 | $0.01 | $0.01 |
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand. The company also manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics under the Gynemed brand; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand. It sells its products and services through a direct sales force in the United States, Germany, France, and the United Kingdom, as well as through distributors to approximately 2,000 fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
Visit WebsiteEarnings History & Surprises
HTLZFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | — | — | — |
Q3 2025 | Aug 12, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | — | — | — |
Q1 2025 | Mar 25, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | $-0.00 | $-0.01 | -1104.8% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-0.00 | $-0.00 | -100.6% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-0.00 | $-0.01 | -400.0% | ✗ MISS |
Q1 2024 | Mar 27, 2024 | — | $0.00 | — | — |
Q4 2023 | Nov 13, 2023 | $0.01 | $-0.01 | -200.0% | ✗ MISS |
Q3 2023 | Aug 17, 2023 | $-0.00 | $-0.00 | -100.7% | ✗ MISS |
Q2 2023 | May 15, 2023 | $0.01 | $0.00 | -94.0% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $0.01 | $0.01 | -18.7% | ✗ MISS |
Q4 2022 | Nov 22, 2022 | $0.00 | $0.00 | -84.5% | ✗ MISS |
Q3 2022 | Aug 23, 2022 | $0.01 | $0.00 | -77.3% | ✗ MISS |
Q2 2022 | Apr 7, 2022 | $0.01 | $0.01 | +42.9% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | $0.01 | $0.01 | +17.4% | ✓ BEAT |
Q4 2021 | Nov 22, 2021 | — | $0.00 | — | — |
Q3 2021 | Aug 18, 2021 | — | $0.00 | — | — |
Q2 2021 | May 25, 2021 | $0.01 | $0.01 | 0.0% | = MET |
Q1 2021 | Feb 18, 2021 | — | $0.01 | — | — |
Latest News
Frequently Asked Questions about HTLZF
What is HTLZF's current stock price?
What is the analyst price target for HTLZF?
What sector is Hamilton Thorne Ltd. in?
What is HTLZF's market cap?
Does HTLZF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HTLZF for comparison